BIGG

Joint ESPGHAN/NASPGHAN guidelines for the management of helicobacter pylori in children and adolescents (Update 2016)

Jones, N. L; Koletzko, S; Goodman, K; Bontems, P; Cadranel, S; Casswall, T; Czinn, S; Gold, B. D; Guarner, J; Elitsur, Y; Homan, M; Kalach, N; Kori, M; Madrazo, A; Megraud, F; Papadopoulou, A; Rowland, M.

J. pediatr. gastroenterol. nutr; 64 (6), 2017

BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...

Helicobacter pylori/isolamento & purificação, Infecções por Helicobacter/tratamento farmacológico, Claritromicina/uso terapêutico, Inibidores da Bomba de Prótons/uso terapêutico, Amoxicilina/uso terapêutico, Metronidazol/uso terapêutico, Infecções por Helicobacter/diagnóstico, Antibacterianos/uso terapêutico, Quimioterapia Combinada

Texto completo

Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics

The use of probiotics has been suggested in the treatment of acute gastroenteritis (AGE) in addition to early rehydration and avoidance of dietary restrictions. This document provides recommendations for the use of probiotics for the treatment of AGE in previously healthy infants and children based on a ...